Literature DB >> 2895231

Amoxycillin/clavulanate resistant Escherichia coli.

G French, T Ling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2895231     DOI： 10.1016/s0140-6736(88)91500-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Comparison of the inoculum effects of members of the family Enterobacteriaceae on cefoxitin and other cephalosporins, beta-lactamase inhibitor combinations, and the penicillin-derived components of these combinations.

Authors:  E J Goldstein; D M Citron; C E Cherubin
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  Effect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of Escherichia coli to beta-lactam antibiotics.

Authors:  P J Wu; K Shannon; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

3.  Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli.

Authors:  P Stapleton; P J Wu; A King; K Shannon; G French; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

4.  Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and beta-lactam-beta-lactamase inhibitor combinations by hyperproduction of SHV-5 beta-lactamase.

Authors:  G L French; K P Shannon; N Simmons
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

Review 5.  Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

6.  Molecular epidemiology of the plasmid-encoded TEM-1 beta-lactamase in Scotland.

Authors:  C J Thomson; S G Amyes
Journal:  Epidemiol Infect       Date:  1993-02       Impact factor: 2.451
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.